WASHINGTON, Jan. 20, 2025 /PRNewswire/ — The National Electrical Contractors Association (NECA) congratulates President Donald J. Trump and Vice President J.D. Vance on their inauguration as the 47th President and 50th Vice President of the United States. NECA with President Trump & Vice…
Category: Uncategorized
NEW YORK, Jan. 20, 2025 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading…
NEW YORK, Jan. 20, 2025 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading…
NEW YORK, Jan. 20, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paladin Energy Ltd (OTC: PALAF) resulting from allegations that Paladin may have issued materially…
NEW YORK, Jan. 20, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paladin Energy Ltd (OTC: PALAF) resulting from allegations that Paladin may have issued materially…
DOWNERS GROVE, Ill., Jan. 20, 2025 /PRNewswire/ — Dover (NYSE: DOV) today announced that it has acquired Cryogenic Machinery Corp. (“Cryo-Mach”). The acquisition will become part of the PSG business within Dover’s Pumps & Process Solutions segment, expanding Dover’s presence in the…
DOWNERS GROVE, Ill., Jan. 20, 2025 /PRNewswire/ — Dover (NYSE: DOV) today announced that it has acquired Cryogenic Machinery Corp. (“Cryo-Mach”). The acquisition will become part of the PSG business within Dover’s Pumps & Process Solutions segment, expanding Dover’s presence in the…
SAN DIEGO, Jan. 20, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on January 20, 2025, the Human Capital Management…
SAN DIEGO, Jan. 20, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on January 20, 2025, the Human Capital Management…
NEW YORK, Jan. 20, 2025 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN) and…
